Curriculum Vitae – PAUL HAHN, MD, PhD, FASRS
Present Position
(2025 - ): Stay tuned
(2016-2025): Vitreoretinal Surgeon - NJ Retina, Teaneck, NJ
Board Certification: Diplomate, American Board of Ophthalmology
(Expires 12/31/2032)
Previous Employment:
2012-2016 Duke University Eye Center, Durham, NC – Assistant Professor of Ophthalmology / Vitreoretinal Surgery and Diseases
Training:
2010-2012 Duke University Eye Center, Durham, NC – Fellow in Vitreoretinal Surgery and Diseases
2007-2010 Scheie Eye Institute/University of Pennsylvania, Philadelphia, PA – Resident in ophthalmology
2006-2007 Presbyterian Medical Center/University of Pennsylvania, Philadelphia, PA – Transitional year intern
Education:
1998-2006 M.D. University of Pennsylvania School of Medicine, Philadelphia, PA
2000-2004 Ph.D. University of Pennsylvania School of Medicine, Philadelphia, PA – Molecular Pharmacology
1994-1998 A.B. Harvard University, Cambridge, MA (magna cum laude, Biochemical Sciences)
1982-1994 The Collegiate School, New York City, NY
National Committee Responsibilities:
2024-present Executive Committee member of American Society of Retina Specialists
2018-present Board member of American Society of Retina Specialists
2024-present Chair of American Society of Retina Specialists Education Committee
2020-2024 Chair of American Society of Retina Specialists Health Economics Committee
2019-present Editor-in-Chief for American Society of Retina Specialists Preferences and Trend Survey
2018-2020 Chair of American Society of Retina Specialists Research and Safety in Therapeutics Committee
2012-2018 Committee member of American Society of Retina Specialists Research and Safety in Therapeutics Committee
Awards/Honors:
2021 Awarded designation as a Fellow of the American Society of Retina Specialists (FASRS)
2021 Selected to serve as an Oral Examiner for the American Board of Ophthalmology
2021 American Academy of Ophthalmology Achievement Award
2016 American Society of Retina Specialists Senior Honor Award
2015-2016 Selected to receive funding for participation in Duke ENhanced Academics in a Basic Laboratory Environment (ENABLE) program
2014 American Society of Retina Specialists Honor Award
2011-2012 Ronald G. Michels Fellowship Award (granted annually to outstanding second-year vitreoretinal fellows)
2010-2011 Heed Ophthalmic Foundation Fellowship. Selected among Heed Fellows into Society of Heed Fellows (in recognition of outstanding credentials)
2010 Association of University Professors of Ophthalmology / Research to Prevent Blindness (AUPO/RPB Resident and Fellow Research Award (selected to present research at annual AUPO meeting)
2009 Selected member of Joint Commission of Allied Health Personnel in Ophthalmology Online Education Committee
2009 Invited participant of American Academy of Ophthalmology Board of Trustees strategic retreat
2008 Selected participant of Heed Ophthalmic Foundation annual retreat
2006 Dr. William F. Jeffers Prize, University of Pennsylvania School of Medicine – meritorious laboratory research in the field of neurosciences
2003 Keystone Symposia Scholarship
2001 ARVO/Retina Research Foundation/Lawrence Travel Grant
1998-2006 MSTP Award for pursuit of M.D./Ph.D. combined degree
1995-1998 John Harvard Scholarship for academic excellence
1994 Detur Prize for Academic Achievement of the Highest Distinction – awarded to top 5-10% of Harvard College first- year students based on academic merit
Notable Clinical Achievements:
2018-present Director of clinical research at NJRetina (Teaneck, NJ)
2019 Performed first Argus II retinal prosthesis implantation in the state of New Jersey.
2016 Invited to teach and supervise surgery of first Argus II implantation in Taiwan
2015-2016 Director of created Duke Center for Artificial and Regenerative Vision to offer novel technologies towards “vision for all blindness.”
2015 Invited to teach and supervise surgery of first Argus II implantation at the University of Colorado (Denver)
2015 Invited to teach and supervise surgery of first Argus II implantation in Istanbul, Turkey.
2014 Performed first Argus II retinal prosthesis implantation in the southeastern United States that was featured with local, regional, national, and international media coverage including (among many others) CNN.com, the Today Show, Bloomberg, Good Morning America, 60 Minutes Australia along with numerous local news stories throughout the world.
Research Experience:
(Note: I have also served as sub-PI/co-investigator on numerous trials not listed below)
2024-present Principal Investigator for Stealth Biotherapeutics-sponsored ReNEW Phase 3 study (A Phase 3, Double-Masked, Placebo-Controlled Clinical trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects Who Have Dry Age-Related Macular Degeneration)
2024-present Principal Investigator for Outlook Pharmaceuticals-sponsored NORSE-8 Phase 3 study (A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration)
2023-present Prinicipal Investigator for Regeneron-sponsored QUASAR study (A Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion)
2022-2024 Principal Investigator for EyePoint Pharmaceuticals-sponsored DAVIO-2 study (A Phase 2 Multicenter, Prospective, Randomized, Double-Masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhbitor (TKI), Compared to Aflibercept, in Subjects with Wet AMD)
2022-present Principal Investigator for Adverum Biotechnologies-sponsored Phase 2 LUNA study (A Multi-Center, Randomized, Double-Masked Phase 2 Study to Assess Safety and Efficacy of ADVM-022 (AAV.8m8-aflibercept) in Anti-VEGF Treatment Experienced Patients with Neovascular (Wet) Age-Related Macular Degeneration”
2022-2024 Principal Investigator for OcuTerra Therapeutics-sponsored DR:EAM study (A Prospective, randomized, double-masked, vehicle controlled, Phase 2 study – Diabetic Retinopathy: Early Active Management)
2021-2023 Principal Investigator for Kodiak-sponsored Phase 3 BEACON study (A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants with Macular Edema due to Retinal Vein Occlusion)
2021-2023 Principal Investigator for Kodiak-sponsored Phase 3 GLEAM study (A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 to Aflibercept in Participants with Diabetic Macular Edema)
2020-present Principal Investigator for Regenxbio-sponsored Phase 2 ALTITUDE trial (RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants with Diabetic Retinopathy without Center Involved Diabetic Macular Edema)
2020-2021 Principal Investigator for Kodiak-sponsored Phase 2b/3 DAZZLE study (A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients with Neovascular (Wet) Age-Related Macular Degeneration)
2020-2022 Principal Investigator for Regeneron-sponsored Phase 2/3 PHOTON study (a Study of High-Dose Aflibercept in Participants with Diabetic Eye Disease)
2020-2022 Prinicipal Investigator for Regeneron-sponsored Phase 2 CANDELA study (Safety, Tolerability, and Efficacy of Aflibercept in Patients with Neovascular Age-Related Macular Degeneration)
2020-2022 Principal Investigator for Novartis-sponsored KINGFISHER study (A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema)
2019-2020 Principal Investigator for Optos/Nikon-sponsored OPT1026 – Sequoia Retinal Image Collection Study
2019-2022 Principal Investigator for Stealth Biotherapeutics-sponsored SPIAM study (A Phase 2, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects with Age-Related Macular Degeneration with Geographic Atrophy)
2019-2020 Principal Investigator for Boehringer-Ingelheim-sponsored ROBIN study (Randomized study of Orally administered BI 1467335 in patients with Non-proliferative diabetic retinopathy without center-involved diabetic macular edema)
2017-2019 Principal Investigator for University of Pennsylvania-sponsored GALA study (Evaluation of Alpha Lipoic Acid as a Potential Treatment for Geographic Atrophy in subjects with Age-related Macular Degeneration)
2014-2018 Principal Investigator and Surgeon for Second Sight Medical Products-sponsored post-approval study for Argus II retinal prosthesis implantation
2014-2016 Principal Investigator for Thrombogenics-sponsored ORBIT trial.
2014-2016 Principal Investigator for Thrombogenics-sponsored OZONE trial.
2010-2016 Co-Investigator of NIH-sponsored research developing a microscope-mounted spectral domain OCT device for intraoperative retinal imaging during vitreoretinal surgery; collaboration with Cynthia Toth, MD (Duke Eye Center) and Joseph Izatt, PhD (Duke Biomedical Engineering).
2010-2016 Co-investigator of research developing a novel microfluidics assay towards point-of-care testing of ocular biomarker levels; collaboration with Glenn Jaffe, MD (Duke Eye Center) and Shashi Murthy, PhD (Northeastern University).
2005-2010 Post-doctoral research in field of retina/ophthalmology investigating retinal iron regulation in laboratory of Joshua Dunaief, MD, PhD – Scheie Eye Institute/F.M. Kirby Center for Molecular Ophthalmology; Univ. Pennsylvania
2000-2004 Mentored research in field of ophthalmology with Joshua Dunaief, MD, PhD (Univ. Pennsylvania School of Medicine); dissertation for PhD degree titled, “Mechanisms of cell death in retinal degeneration: the roles of pro-apoptotic bcl-2 members, bax and bak, and of iron misregulation.”
1996-1998 Mentored research in viral protein crystallography with James Hogle, PhD (Harvard Medical School); honors thesis titled, “Oligomerization of hepatitis delta antigen.”
Editorial Responsibilities:
2022-present Editorial Board: Journal Vitreoretinal Diseases
2020-present Section Editor: Retina Times
2019-present Editor-in-Chief for American Society of Retina Specialists Preferences and Trend Survey
2016-2024 Column Editor: Surgical Pearls (Retinal Specialist)
2016-present Editorial Board: Retinal Specialist
2015-present Associate Editor: Advances in Ophthalmology and Visual System
2014-present Editorial Board: New Retinal Physician
2011-2012 Section Editor: Retina (Photoessays section)
2019-present Ad hoc reviewer: Am J Ophthalmol
2019-present Ad hoc reviewer: Brit J Ophthalmol
2018-present Ad hoc reviewer: Ophthalmol Retina
2015-present Ad hoc reviewer: Ophthalmol Genet
2015-present Ad hoc reviewer: Surv Ophthalmol
2014-present Ad hoc reviewer: Expert Rev Ophthalmol
2014-present Ad hoc reviewer: Clin Ophthalmol
2013-present Ad hoc reviewer: Ophthalmol
2011-present Ad hoc reviewer: Retina
2011-present Ad hoc reviewer: JAMA Ophthalmol
2011-present Ad hoc reviewer: Ophthalmic Surg Lasers Imag
2011-present Ad hoc reviewer: Retinal Cases & Brief Reports
2006-present Ad hoc reviewer: Invest Ophthalmol and Vis Sci
Medical and Research Society Memberships:
2016-present Retina Society
2012-present Vit-Buckle Society
2011-present American Society of Retina Specialists
2010-present Society of Heed Fellows
2006-present American Academy of Ophthalmology
2001-present Association for Research in Vision and Ophthalmology
Peer-Reviewed Publications:
Chen L, Dentchev T, Wong R, Hahn P, Wen R, Bennett J, Dunaief JL. Increased expression of ceruloplasmin in the retina following photic injury. Mol Vis. 2003 Apr 30;9:151-8.
Hahn P, Lindsten T, Ying GS, Bennett J, Milam AH, Thompson CB, Dunaief JL. Proapoptotic bcl-2 family members, Bax and Bak, are essential for developmental photoreceptor apoptosis. Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3598-605.
Hahn P, Milam AH, Dunaief JL. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch’s membrane. Arch Ophthalmol. 2003 Aug;121(8):1099-105.
Hahn P, Dentchev T, Qian Y, Rouault T, Harris ZL, Dunaief JL. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol Vis. 2004 Aug 26;10:598-607.
Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA. 2004 Sep 21;101(38):13850-5.
Hahn P, Lindsten T, Tolentino J, Bennett J, Thompson CB, Dunaief JL. Persistent fetal ocular vasculature in mice deficient in Bax and Bak. Arch Ophthalmol. 2005 Jun;123(6):797-802.
Dentchev T, Hahn P, Dunaief JL. Strong photoreceptor label for iron and the iron handling proteins ferritin and ferroportin in age-related macular degeneration. Arch Ophthalmol. 2005 Dec;123(12):1745-6.
Rex TS, Tsui I, Hahn P, Maguire AM, Duan D, Bennett J, Dunaief JL. Adenovirus-mediated delivery of catalase to RPE cells protects neighboring photoreceptors from photo-oxidative stress. Hum Gene Ther. 2004 Oct;15(10):960-7.
Hahn P, Lindsten T, Lyubarsky A, Ying GS, Pugh EN, Thompson CB, Dunaief JL. Deficiency of Bax and Bak protects photoreceptors from light damage in vivo. Cell Death Differ. 2004 Nov;11(11):1192-7.
Krajacic P, Qian Y, Hahn P, Dentchev T, Gitlin J, and Dunaief JL. Retinal localization and copper-dependent re-localization of the Wilson and Menkes disease proteins. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3129-34.
Hahn P, Ying GS, Beard J, Dunaief JL. Iron levels in human retina: sex difference and increase with age. Neuroreport. 2006 Nov;17(17):1803-6.
He X, Hahn P, Iacovelli J, Wong R, King C, Bhisitkul R, Massaro-Giordano M, Dunaief JL. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 2007 Nov;26(6):649-73.
Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL. Iron Toxicity as a potential factor in AMD. Retina. 2007 Oct;27(8):997-1003.
Hadziahmetovic M, Dentchev T, Song Y, Haddad N, He X, Hahn P, Pratico D, Wen R, Harris ZL, Lambris J, Beard J, Dunaief J. Ceruloplasmin/Hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2728-36.
Bhisitkul RB, Winn BJ, Lee OT, Wong J, Pereira DD, Porco TC, He X, Hahn, P, Dunaief J. Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4071-7.
Hahn P, Song Y, Ying GS, He X, Beard J, Dunaief JL. Age-dependent and gender-specific changes in mouse tissue iron by strain. Exp Gerontol. 2009 Sep;44(9):594-600.
Hahn P, Migacz J, O’Connell R, Maldonado R, Izatt JA, Toth CA. The use of optical coherence tomography in intraoperative ophthalmic imaging. Ophthalmic Surg Lasers Imaging. 2011 Jul;42(4 Suppl):S85-S94.
Hahn P and Fekrat S. Best Practices for Treatment of Retinal Vein Occlusion. Curr Opin Ophthalmol, 2012 May;23(3):175-81.
Lin P, Hahn P, Fekrat S. Peripheral Retinal Vasculitis Demonstrated by Ultra-widefield Fluorescein Angiography in Preeclampsia with HELLP Syndrome. Retina, 2012 Sep;32(8):1689-90.
Hahn P, Migacz J, O’Connell R, Izatt JA, Toth CA. Unprocessed real-time imaging of vitreoretinal surgical maneuvers using a microscope-mounted spectral domain optical coherence tomography system. Graefe’s Arch Clin Exp Ophthalmol, 2013 Jan;251(1):213-20.
Hahn P and Fekrat S. Aflibercept for central retinal vein occlusion – an ongoing revolution or are we spinning in place? Am J Ophthalmol, 2013 Mar;155(3):415-417.
Hahn P, Acquah K, Cousins SW, Lee PP, Sloan FA. Ten year incidence of age-related macular degeneration according to diabetic retinopathy classification among Medicare beneficiaries. Retina, 2013 May:33(5):911-9.
Hahn P, Migacz J, O’Connell R, Day S, Lee A, Lin P, Vann R, Kuo A, Fekrat S, Mruthyunjaya P, Postel EA, Izatt JA, Toth CA. Preclinical evaluation and intraoperative human retinal imaging with a microscope-integrated spectral domain optical coherence device. Retina, 2013 July-Aug;33(7):1328-37.
Hahn P, Kim JE, Stinnett S, Chung MM, Dugel PU, Flynn HW, Huang SS, Sadda SR, Mahmoud TH. Aflibercept-related sterile inflammation. Ophthalmology, 2013 May;120(5):1100-101.e1-5.
Hahn P, Lin P, Fekrat S. Ultra-widefield imaging of Duchenne muscular dystrophy-associated proliferative retinal vasculopathy improved with panretinal laser photocoagulation alone. Ophthalmic Surg Laser Imaging Retina, 2013 May-Jun;44(3):293-5.
Pestana N, Walsh D, Hatch A, Hahn P, Jaffe G, Murthy S, and Niedre M. A Dedicated Low-Cost Fluorescence Microfluidic Device Reader for Point-of-Care Ocular Diagnostics. J Med Devices, 2013 Jun;7(2), 024501.
Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitis macular edema. Ophthalmol, 2013 Sep;120(9):1852-9.
Todorich B, Yiu G, Hahn P. Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis. Expert Rev Clin Pharmacol, 2014 May;7(3):375-91.
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmol. 2014 Oct;121(10):1855-62.
Walsh III DI, Sommer GJ, Schaff UY, Hahn P, Jaffe GJ, Murthy SK. A centrifugal fluidic immunoassay for ocular diagnostics with an enzymatically hydrolyzed fluorogenic substrate. Lab Chip, 2014 Aug;14(15):2673-80.
Yiu G, Fekrat S, Hahn P. Spontaneous peripheral migration of subfoveal perfluorocarbon. Retina. 2014 Nov;23(11):2315-6.
Hahn P. Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye. Clin Ophthalmol. 2014 Oct;8:2129-31.
Hahn P. Simple Surgeon-Controlled Method of Safe, Cost-Effective, and Efficient Application of Chromovitrectomy Agents Through Reflux. Retina. 2015 Feb;35(2):371-3.
Hahn P, Chung MM, Flynn HW Jr, Huang SS, Kim JE, Mahmoud TH, Sadda SR, Dugel PU. Postmarketing analysis of aflibercept-related sterile intraocular inflammation. JAMA Ophthalmol. 2015 Apr;133(4):421-426.
Hahn P, Chung MM, Flynn HW Jr, Huang SS, Kim JE, Mahmoud TH, Sadda SR, Dugel PU. Safety profile of ocriplasmin for symptomatic vitreomacular adhesion – a comprehensive analysis of pre- and post-marketing experiences. Retina. 2015 Jun;35(6):1128-34.
Nam DH, Desouza PJ, Hahn P, Tai V, Sevilla MB, Tran-Viet D, Cunefare D, Farsiu S, Izatt JA, Toth CA. Intraoperative spectral domain optical coherence tomography imaging after internal limiting membrane peeling in idiopathic epiretinal membrane with connecting strands. Retina. 2015 Aug;35(8):1622-30.
Oellers P, Charkoudian L, Hahn P. Spontaneous resolution of subfoveal perfluorocarbon. Clin Ophthalmol. 2015 Mar;9:517-9.
Reddy V, Maldonado RS, Humayun MS, Hahn P. Bionic Eye: A Glance at the Argus II retinal prosthesis. Adv Ophthalmol Vis Syst. 2015; 2(3):00044.
Oellers P, Schneider EW, Fekrat S, Mahmoud TH, Mruthyunjaya P, Hahn P. Retained intraocular perfluoro-n-octane after valved cannula pars plana vitrectomy for retinal detachment. Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):451-6.
Hahn P, Carrasco-Zevallos O, Cunefare D, Migacz J, Farsiu S, Izatt JA, Toth CA. Intrasurgical human retinal imaging with manual instrument tracking using a microscope-integrated spectral domain optical coherence tomography device. Transl Vis Sci Technol. 2015 Jul 1;4(4):1
Hahn P, Yashkin AP, Sloan FA. Increased risk of retained lens fragments and endophthalmitis following cataract surgery in Medicare beneficiaries with prior intravitreal injections. Ophthalmol, 2016 Feb;123(2):309-15.
Grewal DS, Stinnett SS, Folgar FA, Schneider EW, Vajzovic L, Asrani S, Freedman SF, Mruthyunjaya P, Hahn P. A comparative study of rebound tonometry with tonopen and goldmann applanation tonometry following vitreoretinal surgery. Am J Ophthalmol. 2016 Jan;161:22-28.
Oellers P, Stinnett S, Mruthyunjaya P, Hahn P. Small-gauge valved versus non-valved pars plana vitrectomy for retinal detachment repair. Retina, 2016 Apr;36(4):744-9.
Seider MI, Hahn P. Argus II retinal prosthesis malrotation and repositioning with intraoperative optical coherence tomography in a posterior staphyloma. Clin Ophthalmol. 2015 Nov 24;9:2213-6.
Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Am J Ophthalmol. 2016 Apr;164:29-36.
Chen Y, Hahn P, Sloan FA. Changes in Visual Function in the Elderly Population in the United States: 1995-2010. Ophthalmic Epidemiol. 2016 Jun;23(3):137-44.
Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT. Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol. 2016 May 6;16(1):52
Todorich B, Hahn P. Profound vascular stasis of retina and optic nerve following retrobulbar anesthesia. Int Med Case Rep J. 2016 Apr 29;9:109-12.
Shen L, Carrasco-Zevallos O, Keller B, Viehland C, Waterman G, Hahn PS, Kuo AN, Toth CA, Izatt JA. Novel microscope-integrated stereoscopic heads-up display for intrasurgical optical coherence tomography. Biomed Opt Express. 2016 Apr 6;7(5):1711-26.
Oellers P, Stinnett S, Hahn P. Valved versus nonvalved cannula small-gauge pars plana vitrectomy for repair of retinal detachments with Grade C proliferative vitreoretinopathy. Clin Ophthalmol. 2016 May 30;10:1001-6.
Carrasco-Zevallos OM, Keller B, Viehland C, Shen L, Waterman G, Todorich B, Shieh C, Hahn P, Farsiu S, Kuo AN, Toth CA, Izatt JA. Live volumetric (4D) visualization and guidance of in vivo human ophthalmic surgery with intraoperative optical coherence tomography. Sci Rep. 2016 Aug 19;6:31689
Hahn P, Jiramongkolchai K, Stinnett S, Daluvoy M, Kim T. Rate of intraoperative complications during cataract surgery following intravitreal injections. Eye. 2016 Aug;30(8):1101-9.
Yashkin AP, Hahn P, Sloan FA. Introducing anti-vascular endothelial growth factor therapies for AMD did not raise risk of myocardial infarction, stroke, or death. Ophthalmology. 2016 Oct;123(10):2225-31.
Seider MI, Nomides RE, Hahn P, Mruthyunjaya P, Mahmoud TH. Scleral buckling with chandelier illumination. J Ophthalmic Vis Res. 2016 Jul-Sept;11(3):304-9.
Grewal DS, Carrasco-Zevallos OM, Gunther R, Izatt JA, Toth CA, Hahn P. Intra-operative microscope-integrated swept-source optical coherence tomography guided placement of Argus II retinal prosthesis. Acta Ophthalmol. 2017 Aug;95(5):e431-432.
Hahn P, Schneider EW, Tabandeh H, Wong RW, Emerson GG; American Society of Retina Specialists Research and Safety in Therapeutics (ASRS ReST) Committee. Reported complications following laser vitreolysis. JAMA Ophthalmol. 2017 Sep; 135(9):973-976.
Gregori NZ, Callaway NF, Hoeppner C, Yuan A, Rachitskaya A, Feuer W, Ameri H, Arevalo JF, Augustin AJ, Birch DG, Dagnelie G, Grisanti S, Davis JL, Hahn P, Handa JT, Ho AC, Huang SS, Humayun MS, Iezzi R Jr, Jayasundera KT, Kokame GT, Lam BL, Lim JI, Mandava N, Montezuma SR, Olmos de Koo L, Szurman P, Vajzovic L, Wiedemann P, Weiland J, Yan J, Zacks DN. Retinal anatomy and electrode array position in retinitis pigmentosa patients after Argus II implantation: an international study. Am J Ophthalmol. 2018 Sep;193:87-99.
Hahn P, Fine HF. Practical Concepts with the Argus II Retinal Prosthesis. Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 1:49(10):742-746.
Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS. Adverse Events of the Argus II Retinal Prosthesis: Incidecne, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. Retina 2018; Nov 20; epub ahead of print
Seider MI, Carrasco-Zevallos OM, Gunther R, Viehland C, Keller B, Shen L, Hahn P, Mahmoud TH, Dandridge A, Izatt JA, Toth CA. Real-Time Volumetric Imaging of Vitreoretinal Surgery with a Prototype Microscope-Integrated Swept-Source OCT Device. Ophthalmol Retina. 2018 May;2(5):401-410.
Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga P, da Cruz L, Walter P, Augustin AJ, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R, Gaucher D, Arevalo JF, Gregori NZ, Wiedemann P, Özmert E, Lim JI, Rezende FA, Huang SS, Merlini F, Patel U, Greenberg RJ, Justus S, Bacherini D, Cinelli L, Humayun MS. Hypotony and the Argus II retinal prosthesis: causes, prevenetion, and management. Br J Ophthalmol. 2020 Apr;104(4):518-523.
Mikhail M, Jiang S, Hahn P, Orlin A, Rao, RC, Choudhry, N. OCTA: A Practical Method of Image Averaging Using Adobe Photoshop Software. Ophthalmic Surg Lasers Imaging Retina. 2019 Dec 1;50(12):802-807.
Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga P, da Cruz L, Walter P, Augustin AJ, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R, Gaucher D, Arevalo JF, Gregori NZ, Wiedemann P, Özmert E, Lim JI, Rezende FA, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS. Adverse events of the Argus II Retinal Prosthesis: Incidence, causes, and best practices ofr managing and preventing conjunctival erosion. Retina. 2020 Feb;40(2):303-311.
Kim BJ, Hunter A, Brucker AJ, Hahn P, Gehrs K, Patel A, Edwards AO, Li Y, Khurana RN, Nissim I, Daniel E, Grunwald J, Ying GS, Pistilli M, Maguire MG, Dunaief JL. Orally administered alpha lipoic acid as a treatment for geographic atrophy: a randomized clinical trial. Ophthalmol Retina. 2020 Sep;4(9):889-898.
Witkin AJ, Hahn P*, Murray TG, Arevalo JF, Blinder KJ, Choudhry N, Emerson GG, Goldberg RA, Kim SJ, Pearlman J, Schneider EW, Tabandeh H, Wong RW. Occlusive retinal vasculitis following intraviteal brolucizumab. J Vitreoretin Dis. 2020 Jul;4(4):269-279. (*corresponding author)
Witkin AJ, Hahn P*, Murray TG, Arevalo JF, Blinder KJ, Choudhry N, Emerson GG, Goldberg RA, Kim SJ, Pearlman J, Schneider EW, Tabandeh H, Wong RW. Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis. J Vitreoretin Dis. 2021 Jul;5(4):326-332. (*corresponding author)
Hahn P, Blim JF, Packo K, Jumper JM, Murray T, Awh CC. The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their Patients. J Vitreoretin Dis. 2021
DeRuyter NP, Patel S, Chen Q, Leder H, Leung E, Reddy R, Blim J, Awh CC, Hahn P; Health Economics Committee, American Society of Retina Specialists. Trends in Medicare Reimbursement for Common Vitreoretinal Procedures: 2011-2020. Ophthalmol. 2022 Jul;129(7):829-31.
Leung EH, Leder HA, Patel S, Reddy R, Boucher N, Sharma C, Blim J, Awh C, Hahn P. Opportunity Cost of Retina Detachment Surgery vs Office-Based Patient Care. J Vitreoretin Dis. 2022; 6(4):278-283.
Sodhi GS, Haq Z, Aggarwal N, Boucher N, Emerson GG, Hahn P. Evolving Treatment Patterns in Diabetic Macular Edema Between 2015 and 2020. J Vitreoretin Dis. 2023 Mar;7(3):199-202.
Mulligan K, Kim J, Tysinger B, Blim J, Emerson G, Ferrone PJ, Kim JE, Seabury S, Hahn P. The Broader Economic Value of Treatment for Diabetic Macular Edema. Diabetes Care. 2023 Apr: online ahead of print.
Leung EH, Patel S, Reddy R, Boucher N, Sharma C, Blim J, Ferrone PJ, Hahn P. Opportunity Cost of Vitreoretinal Surgeries. J Vitreoretin Dis. 2023 Jun 17;7(4):275-80.
Grewal DS, Leung EH, Busquets M, Niles P, Gong DA, Kolomeyer AM, Aggarwal N, Boucher N, Blim J, Kim JE, Sanders R, Hahn P. Bevacizumab-first in DRCR Protocol AC versus Real-world physician treatment choice for diabetic macular edema: a two-year cost analysis.” J Vitreoretin Dis. In press.
Book Chapters:
Hahn P, Mruthyunjaya P, Fekrat S. Central retinal vein occlusion. In: Retina . Fifth ed. Eds. Ryan SJ, Murphy R, Schachat AP. Chapter 70, Elsevier Inc, Philadelphia, 2011.
Hahn P and Fekrat S. Treatment of Retinal Vein Occlusion: Lessons from Clinical Trials. In: Evidence-Based Eye Care, Second ed. Eds. Kertes PJ and Johnson TM.
Hahn P, Bearelly S, Green WR, and Fekrat S. Ciliochoroidal Effusion. In: Duane’s Ophthalmology. Eds: Tasman W and Jaeger EA.
Hahn P and Fekrat S. Central Retinal Vein Occlusion. In: Encyclopedia of Ophthalmology. Ed: Erfurth-Schmidt U. Springer Verlag, Berlin 2015.
Migacz JV, Carrasco-Zevallos O, Hahn P, Kuo A, Toth CA, Izatt JA. Intraoperative retinal optical coherence tomography. In: Optical Coherence Tomography. Eds: Drexler W, Fujimoto JG. Chapter 58, Springer International Publishing, Switzerland 2015.
Oellers P, Hahn P, Fekrat S. Central retinal vein occlusion. In: Retina . Sixth ed. Eds. Sadda S, Schachat AP. Elsevier Inc, Philadelphia 2017.
Zhang W and Hahn P. Unusual Site Thrombosis – Thrombosis in the retinal circulation. In: Handbook of Venous Thromboembolism. Ed: Thachil J and Bagot C. John Wiley and Sons Ltd, UK 2018.
Hahn P. What is a retinal prosthesis (Argus II implant) and who would be a good candidate for it? In: Curbside Consultations in Retina: 49 Clinical Questions, 2nd Edition. Ed: Fekrat S.
Oellers P, Hahn P, Ip, M, Fekrat S. Central retinal vein occlusion. In: Retina . Seventh ed. Eds. Sadda S, Schachat AP. Elsevier Inc, Philadelphia 2022.
Select national and international meeting presentations:
(oral presentations noted by **)
** Hahn P, Lindsten T, Tolentino M, Bennett J, Milam AH, Thompson C, Dunaief J.
Bax and Bak are Essential for Developmental Apoptosis of Ocular Fetal Vasculature and INL Photoreceptors. Invest Ophthalmol Vis Sci. 2002 43: E-Abstract 829.
Chen L, Dentchev T, Wong R, Zeng Y, Hahn P, Wang Y, Wen R, Baldwin D, Bennett J, Dunaief JL. Increased Expression of Ceruloplasmin in the Retina following Photic Injury. Invest Ophthalmol Vis Sci. 2003 44: E-Abstract 5130.
Hsu J, Hahn P, Lindsten T, Ying GS, Tolentino M, Bennett J, Milam AH, Thompson CB, Dunaief JL. Bax and Bak Are Essential, Overlapping Mediators of Apoptotic Developmental Regression of the Hyaloid Vasculature and of Retinal Neurons Including Photoreceptors. Invest Ophthalmol Vis Sci. 2003 44: E-Abstract 1608.
Wong R, Hahn P, Harris ZL, Dunaief JL. Ceruloplasmin and Hephaestin Serve Overlapping Regulatory Functions in Ocular Iron Homeostasis. Invest Ophthalmol Vis Sci. 2003 44: E-Abstract 465.
Hahn P, Milam AH, Dunaief JL. Human AMD Maculas Contain Increased Chelatable Iron in the RPE and Bruch’s Membrane. Invest Ophthalmol Vis Sci. 2003 44: E-Abstract 1733.
** Hahn P, Chen L, Beard JL, Harris ZL, Dunaief JL. Disruption of Ceruloplasmin and Hephaestin in mice causes retinal iron overload and retinal degeneration with features of age–related macular degeneration. ARVO Meeting Abstracts, 2004 45: E-Abstract 2292.
Dunaief JL, Hahn P, Rouault T, Harris ZL. Retinal iron metabolism and its possible role in AMD pathogenesis. ARVO Meeting Abstracts, 2004 45: E-Abstract 2291.
Qian Y, Dentchev T, Krajacic P, Hahn P, Dunaief JL. Iron Overloaded Cp–/–Heph–/– Retinas Exhibit Increased Light Damage and Thinning of Outer Nuclear Layer. ARVO Meeting Abstracts, 2005 46: E-Abstract 1647.
Krajacic P, Qian Y, Hahn P, Dentchev T, Lukinova N, Dunaief JL. Retinal Localization and Copper Dependent Re–Localization of the Wilson and Menkes Disease Proteins. ARVO Meeting Abstracts, 2006 47: E-Abstract 2892.
King C, Krajacic P, Qian Y, Dentchev T, Ligato N, Hahn P, Dunaief JL. Retinal Degeneration and Neovascularization in Iron Overloaded Cp/Heph Deficient Mice is Exacerbated by Bright Light Exposure and Aging. ARVO Meeting Abstracts, 2006 47: E-Abstract 2592.
Dentchev TI, Hahn P, Dunaief JL. A Preliminary Postmortem Study Of Amd Eyes Treated in The CAPT Trial. ARVO Meeting Abstracts, 2006 47: E-Abstract 2111.
Iacovelli J, Ojha P, Gollomp K, Hahn P, Donovan A, Andrews N, Dunaief JL.
The Iron Exporter Ferroportin Plays A Role In Retinal Iron Homeostasis. ARVO Meeting Abstracts, 2006 47: E-Abstract 4157.
Hahn P, Song Y, He X, Beard J, Dunaief JL. Correlation of Tissue Iron Levels With Age in C57BL/6, DBA/J, and Balb/c Mice. ARVO Meeting Abstracts, 2008 49: E-Abstract 5925.
Hadziahmetovic M, Song Y, Dentchev T, Haddad N, He X, Hahn P, Wen R, Dunaief JL. Ceruloplasmin/Hephaestin Knockout Mice Model Morphologic and Mechanistic Features of AMD. ARVO Meeting Abstracts, 2008 49: E-Abstract 3416.
Iacovelli J, Veldman P, Ojha P, Hahn P, Donovan A, Andrews N, Dunaief JL. The Iron Exporter Ferroportin Plays A Role in Retinal Iron Homeostasis. ARVO Meeting Abstracts, 2008 49: E-Abstract 214.
Hahn P, Song Y, Grieco G, Pook MA, Dunaief JL. Photoreceptor Degeneration in a Mouse Model of Friedreich Ataxia. ARVO Meeting Abstracts, 2009 50: E-Abstract 4498.
** Hahn P, Migacz, J, Tao, YK, Ehlers JP, Izatt JA, Toth, CA. Real Time Cross-Sectional Intra-Surgical Imaging Of Retinal Structures Using A Microscope-Mounted OCT System. ARVO Meeting Abstracts, 2011 52: E-Abstract 4498.
Hahn P, Migacz J, O’Connell R, Izatt JA, Toth CA. Unprocessed real-time imaging of vitreoretinal surgical maneuvers using a microscope mounted spectral domain optical coherence tomography system. American Society of Retinal Specialists Annual Meeting, August 2011. Boston, MA.
Migacz J, Hahn P, Moustafa Z, O’Connell R, Moreno T, Thomas C, Wang C, Chiu S, Dai L, Farsiu S, Toth CA, Izatt JA. Instrument tip-tracking ophthalmic intrasurgical SDOCT. SPIE, January 2012, San Francisco, CA.
Lin P, Hahn P, Fekrat S. Duchenne Muscular Dystrophy-associated Proliferative Retinal Vasculopathy Successfully Treated With Panretinal Laser Photocoagulation. ARVO Meeting Abstracts, 2012 53:977.
Migacz JV, Moustafa Z, Chiu SJ, Moreno T, Hahn P, O'Connell R, Farsiu S, Toth CA, Izatt JA. Surgical Instrument Tracking Image Guidance for Intraoperative OCT ARVO Meeting Abstracts, 2012 53:3125.
Hahn P, Migacz J, O’Connell R, Yuan E, Moreno T, Izatt JA, Toth CA. Initial Experience With Human Imaging Of Vitreoretinal Surgical Maneuvers Using A Custom Microscope-Mounted Spectral Domain Optical Coherence Device. ARVO Meeting Abstracts, 2012 53:3115.
** Hahn P, Lin P, Fekrat S. Duchenne muscular dystrophy-associated proliferative retinal vasculopathy successfully treated with laser photocoagulation. American Society of Retinal Specialists Annual Meeting. August 2012. Las Vegas, NV.
** Hahn P, Migacz J, O’Connell R, Moreno T, Yuan E, Izatt JA, Toth CA. Preclinical evaluation and intraoperative human retinal imaging with a Microscope-Integrated spectral domain Optical Coherence Tomography device. American Society of Retinal Specialists Annual Meeting. August 2012. Las Vegas, NV.
** Hahn P, Lin P, Fekrat S. Duchenne muscular dystrophy-associated proliferative retinal vasculopathy successfully treated with laser photocoagulation. Retina Society Annual Meeting. October 2012. Washington, DC.
** Hahn P. Dramatic and Atypical Vascular Changes at Surgical Start. American Society of Retinal Specialists Annual Meeting. August 2013. Toronto, CAN.
** Yiu G, Martel J, Hahn P. Spontaneous Migration of Subfoveal Perfluorocarbon. American Society of Retinal Specialists Annual Meeting. August 2013. Toronto, CAN.
** Hahn P, Kim JE, Stinnett S, Chung MM, Dugel PU, Flynn HW, Huang SS, Sadda SR, Mahmoud TH. A Cluster of Sterile Inflammation Associated With Aflibercept Intravitreal Injections—An ASRS Therapeutic Surveillance Committee Report. American Society of Retinal Specialists Annual Meeting. August 2013. Toronto, CAN.
** Hahn P, Chung MM, Flynn HW, Huang SS, Kim JE, Mahmoud TH, Sadda SR, Dugel PU. Safey Profile of Ocriplasmin in Symptomatic VMA – A Comprehensive Review of Pre- and Post-Marketing Safety Experiences – An ASRS Therapeutic Surveillance Committee Report. American Academy of Ophthalmology Retina Subspecialty Day. November 2013. New Orleans, LA.
Hahn P. The role for ophthalmoscopy in the ongoing management of retinal diseases in the current era of high resolution OCT imaging. American Academy of Ophthalmology Annual Meeting. November 2013. New Orleans, LA.
** (Invited lecturer) Hahn P. A Novel Microscope-integrated Optical Coherence Tomography (MIOCT) Device for Real-time Imaging of Vitreoretinal Surgical Manipulations. Translational Advances in Ophthalmology. January 2014. Singapore.
** (Invited lecturer) Hahn P. Swept-source and beyond: advancing the next generation of intrasurgical OCT. 1st Intraoperative OCT Science Day. February 2014. Vienna, Austria.
** Hahn P. Uses for and Pitfalls of Perfluorocarbon Liquids. Vit-Buckle Society Annual Meeting. March 2014. Las Vegas, NV.
** Hahn P. Perfluorocarbon Liquids: Can’t Live With It, Can’t Live Without It. Duke Advanced Vitreoretinal Surgery Course. March 2014. Durham, NC.
** Hahn P, Chung MM, Flynn HW, Huang SS, Kim JE, Mahmoud TH, Sadda SR, Dugel PU. Safey Profile of Ocriplasmin in Symptomatic VMA – A Comprehensive Review of Pre- and Post-Marketing Safety Experiences – An ASRS Therapeutic Surveillance Committee Report. Association for Research in Vision and Ophthalmology, May 2014. Orlando, FL.
** Hahn P, Carrasco-Zevallos O, Farsiu S, Kuo A, Izatt JA, Toth CA. Next generation intrasurgical imaging with a swept-source microscope-integrated optical coherence tomography device. American Society of Retinal Specialists Annual Meeting. August 2014. San Diego, CA.
** Hahn P. Use of Valved Cannulas for Vitrectomy. Vit-Buckle Society Annual Meeting. March 2015. Miami, FL.
** Hahn P. Relaxing Retinectomy for Posterior Breaks. Vit-Buckle Society Annual Meeting. March 2015. Miami, FL.
** Hahn P. The Argus II – an epiretinal prosthesis. Duke Advanced Vitreoretinal Surgery Course. March 2015. Durham, NC.
Hahn P, Oellers P, Stinnett S. Outcomes And Complications Of Valved Versus Non-Valved Small Gauge Pars Plana Vitrectomy For Retinal Detachment Repair. American Society of Retinal Specialists Annual Meeting. July 2015. Vienna, Austria.
** Hahn P. Increased risk of surgical complications, postoperative glaucoma, and endophthalmitis with cataract surgery following intravitreal injections. American Society of Retinal Specialists Annual Meeting. July 2015. Vienna, Austria.
** Hahn P. Are we better than we were 10 years ago? An analysis of retinal detachment outcomes. Vail Vitrectomy meeting. February 2016. Vail, CO.
** Hahn P. Are we better than we were 10 years ago? An analysis of retinal detachment outcomes. American Society of Retinal Specialists Annual Meeting. August 2016. San Diego, CA
** Hahn P, Tsuboi M, Francom S, Quezada-Ruiz C, Haskova Z. Ranibizumab improved vision in patients with myopic choroidal neovascularization: results from the Phase III RADIANCE trial. American Society of Retinal Specialists Annual Meeting. August 2017. Boston, MA
** Hahn P, Tsuboi M, Francom S, Quezada-Ruiz C, Haskova Z. Ranibizumab treatment provides significant vision gains in patients with myopic choroidal neovascularization: results from the Phase III RADIANCE trial. Retina Society Annual Meeting. October 2017. Boston, MA
** Hahn P, Tabandeh H, Wong RW, Schneider EW, Lim JI, Emerson GG. Complications following laser vitreolysis for symptomatic floaters. American Society of Retinal Specialists Annual Meeting. August 2018. Vancouver, CA
** Hahn P, Stone T, Raef S, Schneidermann M. 2018 Preferences and Trends Survey: A trending overview. American Society of Retinal Specialists Annual Meeting. August 2018. Vancouver, CA
** Hahn P, Brown D, Dugel PU, Emerson GG, Kim J. Avastin: A Changing Landscape. American Society of Retinal Specialists Annual Meeting. July 2019. Chicago, IL
** Hahn P. 2019 Preferences and Trends Survey: A trending overview. American Society of Retinal Specialists Annual Meeting. July 2019. Chicago, IL.
** Hahn P, Tsuboi M, Blotner S, Stoilov I. Predicting long-term response to ranibizumab after three injection in patients with age-related macular degeneration. American Society of Retinal Specialists Annual Meeting. July 2020 (virtual)
** Hahn P, Eliott D, Emerson GG, Heier JS, Yeh S. ASRS ReST Committee – Drug Safety Update. American Society of Retinal Specialists Annual Meeting. July 2020 (virtual)
** Hahn P, Tsuboi M, Blotner S, Stoilov I. Predicting long-term response to ranibizumab after three injection in patients with age-related macular degeneration. Retina Society Annual Meeting. July 2020 (virtual)
** Hahn P. Update on brolucizumab-related inflammation. American Academy of Ophthalmology Subspecialty Day. October 2020 (virtual).
** Hahn P. The impact of COVID-19 on US and international retina specialists, their practices, and their patients. American Society of Retina Specialists Annual Meeting, July 2021. San Antonio, TX.
** Hahn P. 2021 Preferences and Trends Survey: A trending overview. American Society of Retina Specialists Annual Meeting, July 2021. San Antonio, TX.
** Hahn P. Chromovitrectomy – the old and the new. OSN Retina 2021Annual Meeting. New York, NY.
** Hahn P. The risk-benefit ratio of brolucizumab is not acceptable. American Academy of Ophthalmology Retina Subspecialty Day. November 2021. New Orleans, LA.
** Hahn P, Emerson GG, Blim J, Ferrone P, Mulligan K, Seabury S. Benefits and value of treatment for diabetic macular edema. American Society of Retina Specialists Annual Meeting, July 2022. New York, NY.
** Hahn P. 2022 Preferences and Trends Survey: A trending overview. American Society of Retina Specialists Annual Meeting, July 2022. New York, NY.
** Hahn P, Eichenbaum D, Sarda SP, Sharp D, Intorcia M, Luo R, Bobbili P, Chang R, Catillon M, Xu C, Sarathy K, Duh MS, Chaudhary V. Pegcetacoplan vs Avacincaptad Pegol in Patients with Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of the Phase 3 Trials. American Society of Retina Specialists Annual Meeting, July 2023. Seattle, WA.
** Hahn P. 2023 Preferences and Trends Survey: A trending overview. American Society of Retina Specialists Annual Meeting, July 2023. Seattle, WA.
** Hahn P. Invited guest lecturer for 14th Congress of the CSCRS – New Trends in Ophthalmology. “Beyond Monthly Injections – The Present and Future of AMD Treatments.” September 2023. Zagreb, Croatia.
** Hahn P. 2024 Preferences and Trends Survey: A trending overview. American Society of Retina Specialists Annual Meeting, July 2024. Stockholm, Sweden.
** Hahn P, Dhoot D, Zarbin M, Chaudhary, V, Eichenbaum, Intorcia M, Jones D, Sarda SP, Bobbili P, Chang R, Xu C, Sarathy K, Catilion M, Duh MS, Baumal CR. Pegcetacoplan vs Avacincaptad Pegol in Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of Three Phase 3 Trials. American Society of Retina Specialists Annual Meeting, July 2024. Stockholm, Sweden.
** Hahn P. Step Therapy Cost (In)Effectiveness and Inflationary Adjustments. American Academy of Ophthalmology Retina Subspecialty Meeting. October 2024. Chicago, IL.
Select Educational Presentations:
Invited lecturer for “Updates in Diabetic Retinopathy.” Endocrinology Grand Rounds – Duke University Medical Center. November 2012. Durham, NC.
Invited Guest Moderator for Wake Forest University Retina Journal Club, June 2013. Winston Salem, NC.
Invited lecturer for podcast on “Aflibercept for central retinal vein occlusion – an ongoing revolution or are we spinning in place?”; As Seen from Here, June 2013.
Invited lecturer for CME course on “Aflibercept related sterile inflammation.” RetinaCME.com, August 2013.
Course Director for American Society of Retina Specialists instructional course: “Duke Surgery Rounds: Deconstructing PPV from A-to-Z.” American Society of Retina Specialists Annual Meeting, August 2013. Toronto, CA.
Faculty for AAO Spotlight Course: “Ophthalmic Emergencies.” American Academy of Ophthalmology Annual Meeting. November 2013. New Orleans, LA.
Faculty for AAO instructional course: “Duke Surgery Rounds.” American Academy of Ophthalmology Annual Meeting. November 2013. New Orleans, LA.
Invited lecturer for podcast on “Intrasurgical OCT imaging.” American Society of Retina Specialists Podcast Series. January 2013.
Course Director for American Society of Retina Specialists webinar: “Small Gauge-Vitrectomy: Nuts, Bolts, and Valuable Pearls.” March 2014.
Course Director for inaugural vitreoretinal wetlab course: “Duke Advanced Surgery Rounds: A Hands-On Approach.” Duke Advanced Vitreoretinal Surgery Course. March 2014. Durham, NC.
Course Director for American Society of Retina Specialists instructional course: “Duke Surgery Rounds: 7 Tips You Must Know!” American Society of Retina Specialists Annual Meeting, August 2014. San Diego, CA.
Invited faculty for American Society of Retina Specialists hands-on wetlab instructional course. American Society of Retina Specialists Annual Meeting. August 2014. San Diego, CA.
Course director for American Academy of Ophthalmology instructional course: “From Front to Back: managing posterior segment complications of anterior segment surgery.” American Academy of Ophthalmology Annual Meeting. October 2014. Chicago, IL.
Organizing Committee for Duke Advanced Vitreoretinal Surgery Course. April 2015. Durham, NC.
Course Director for vitreoretinal wetlab course: “Duke Advanced Surgery Rounds: A Hands-On Approach.” Duke Advanced Vitreoretinal Surgery Course. April 2015. Durham, NC.
Invited faculty for American Society of Retina Specialists instructional course: “Surgery Rounds: What would Machemer do?” American Society of Retina Specialists Annual Meeting, July 2015. Austria, Vienna.
Invited faculty for Bausch & Lomb Fellows Program, August 2015
Invited faculty for American Academy of Ophthalmology instructional course: “Surgery Rounds: The case of your career” American Academy of Ophthalmology Annual Meeting, November 2015. Las Vegas, NV.
Invited faculty for vitreoretinal wetlab course: “Duke Advanced Surgery Rounds: A Hands-On Approach.” Duke Advanced Vitreoretinal Surgery Course. April 2016. Durham, NC.
Invited faculty for American Society of Retina Specialists instructional course: “Argus II retinal prosthesis implantation.” American Society of Retina Specialists Annual Meeting, August 2016. San Diego, CA.
Invited faculty for American Society of Retina Specialists instructional course: “Argus II retinal prosthesis implantation.” American Society of Retina Specialists Annual Meeting, August 2017. Boston, MA.
Invited faculty for Vit-Buckle Society Surgical Fellows Forum. Vit-Buckle Society Annual Meeting. March 2018. Miami, FL.
Invited faculty for American Academy of Ophthalmology instructional course: “Vitreoretinal Surgery Complications.” American Academy of Ophthalmology Annual Meeting. October 2019. San Francisco, CA.
Invited faculty for American Academy of Ophthalmology instructional course: “Vitreoretinal Surgery Complications.” American Academy of Ophthalmology Annual Meeting. October 2020 (virtual).
Invited faculty for American Academy of Ophthalmology instructional course: “Vitreoretinal Surgery Complications.” American Academy of Ophthalmology Annual Meeting. November 2021 (virtual).
Course Director for American Society of Retina Specialists course: “Vitreoretinal Surgery Rounds.” American Society of Retina Specialists Annual Meeting. July 2022. New York, NY.
Invited faculty for American Academy of Ophthalmology instructional course: “Vitreoretinal Surgery Complications.” American Academy of Ophthalmology Annual Meeting. November 2022. Chicago, IL.
Course Director for American Academy of Ophthalmology instructional course: “The retinal debates continue.” American Academy of Ophthalmology Annual Meeting. November 2022. Chicago, IL.
Invited faculty for American Academy of Ophthalmology instructional course: “The retinal debates continue.” Talk on “Dry AMD therapeutics are a foundational change.” American Academy of Ophthalmology Annual Meeting. November 2022. Chicago, IL.
Invited panelist for OSN Retina NY case conference. OSN Retina NY Annual Meeting. November 2022. New York, NY.
Invited faculty for Duke Fellows Advanced Vitreoretinal Surgery Course, March 2023, Durham, NC
Invited faculty for Duke Advanced Vitreoretinal Surgery Course, March 2023, Durham, NC
Moderator and director for panel discussion: “2023 Preferences and Trends in Retina.” American Society of Retina Specialists Annual Meeting. July 2023. Seattle, WA.
Invited faculty for American Academy of Ophthalmology instructional course: “Vitreoretinal Surgery Complications.” American Academy of Ophthalmology Annual Meeting. November 2023. San Francisco, CA.
Invited faculty for American Academy of Ophthalmology instructional course: “Anterior Segment Complications of Vitreoretinal Surgery.” American Academy of Ophthalmology Annual Meeting. November 2023. San Francisco, CA.
Invited faculty for American Academy of Ophthalmology instructional course: “Vitreoretinal Surgery Complications.” American Academy of Ophthalmology Annual Meeting. October 2024. Chicago, IL.